EA201500065A1 - Инъецируемый супернасыщенный раствор ацетаминофена для спинального введения - Google Patents

Инъецируемый супернасыщенный раствор ацетаминофена для спинального введения

Info

Publication number
EA201500065A1
EA201500065A1 EA201500065A EA201500065A EA201500065A1 EA 201500065 A1 EA201500065 A1 EA 201500065A1 EA 201500065 A EA201500065 A EA 201500065A EA 201500065 A EA201500065 A EA 201500065A EA 201500065 A1 EA201500065 A1 EA 201500065A1
Authority
EA
Eurasian Patent Office
Prior art keywords
injectable
spin injection
solution
acetaminophen solution
acetaminophen
Prior art date
Application number
EA201500065A
Other languages
English (en)
Other versions
EA028909B1 (ru
Inventor
Аугусто Митидьери
Элизабетта Донати
Никола Каронцоло
Original Assignee
Синтетика С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46690603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201500065(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Синтетика С.А. filed Critical Синтетика С.А.
Publication of EA201500065A1 publication Critical patent/EA201500065A1/ru
Publication of EA028909B1 publication Critical patent/EA028909B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к инъецируемому водному раствору ацетаминофена для применения в лечении или предупреждении боли путем спинального введения, при этом указанный инъецируемый раствор ацетаминофена является супернасыщенным. В некоторых вариантах осуществления инъецируемый водный раствор ацетаминофена вводят одновременно, раздельно или последовательно с местным анестетиком путем спинального введения.
EA201500065A 2012-06-29 2013-06-27 Инъецируемый супернасыщенный раствор ацетаминофена для спинального введения EA028909B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001154A ITMI20121154A1 (it) 2012-06-29 2012-06-29 Soluzione iniettabile di acetaminofene per la somministrazione spinale
PCT/IB2013/055277 WO2014002042A1 (en) 2012-06-29 2013-06-27 Injectable supersaturated acetaminophen solution for spinal administration

Publications (2)

Publication Number Publication Date
EA201500065A1 true EA201500065A1 (ru) 2015-10-30
EA028909B1 EA028909B1 (ru) 2018-01-31

Family

ID=46690603

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201500065A EA028909B1 (ru) 2012-06-29 2013-06-27 Инъецируемый супернасыщенный раствор ацетаминофена для спинального введения

Country Status (44)

Country Link
US (2) US11344517B2 (ru)
EP (1) EP2874602B1 (ru)
JP (1) JP5876620B2 (ru)
KR (1) KR102118227B1 (ru)
CN (1) CN104487051B (ru)
AP (1) AP2014008152A0 (ru)
AR (1) AR091633A1 (ru)
AU (1) AU2013282753B2 (ru)
BR (1) BR112014032818B1 (ru)
CA (1) CA2876801C (ru)
CL (1) CL2014003536A1 (ru)
CO (1) CO7240357A2 (ru)
CR (1) CR20150036A (ru)
CU (1) CU20140150A7 (ru)
CY (1) CY1117691T1 (ru)
DK (1) DK2874602T3 (ru)
DO (1) DOP2014000302A (ru)
EA (1) EA028909B1 (ru)
EC (1) ECSP15000500A (ru)
ES (1) ES2578012T3 (ru)
GE (1) GEP201706689B (ru)
HR (1) HRP20160706T1 (ru)
HU (1) HUE029431T2 (ru)
IL (1) IL236423A (ru)
IT (1) ITMI20121154A1 (ru)
MA (1) MA37811B1 (ru)
MD (1) MD4537C1 (ru)
ME (1) ME02431B (ru)
MX (1) MX369264B (ru)
MY (1) MY169251A (ru)
NI (1) NI201400147A (ru)
NZ (1) NZ703829A (ru)
PE (1) PE20150331A1 (ru)
PH (1) PH12015500178A1 (ru)
PL (1) PL2874602T3 (ru)
PT (1) PT2874602T (ru)
RS (1) RS54844B1 (ru)
SG (2) SG10201704482YA (ru)
SI (1) SI2874602T1 (ru)
SM (1) SMT201600248B (ru)
TN (1) TN2014000526A1 (ru)
UA (1) UA117101C2 (ru)
WO (1) WO2014002042A1 (ru)
ZA (1) ZA201409478B (ru)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646400B1 (en) * 1993-04-14 2001-07-18 Nippon Sanso Corporation Dissolved oxygen reducing apparatus
US6171298B1 (en) * 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
SK2822004A3 (sk) * 2001-12-18 2005-01-03 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenterálny prípravok obsahujúci paracetamol
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) * 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
US9943479B2 (en) * 2006-07-18 2018-04-17 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
CN101015542A (zh) * 2007-02-13 2007-08-15 天津生机集团有限公司 家畜用复方对乙酰氨基酚注射液及其制备方法
MD3528G2 (ru) * 2007-09-28 2008-11-30 Сергей ШАНДРУ Метод продленной спинальной анестезии у пожилых пациентов
US9399012B2 (en) * 2007-11-13 2016-07-26 Mallinckrodt Ip Reduced dose intravenous acetaminophen
WO2009098716A2 (en) 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
WO2009143558A1 (en) 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
JP2013006770A (ja) 2009-10-09 2013-01-10 Ssp Co Ltd アセトアミノフェン含有経口液剤
CA2802303C (en) * 2010-06-30 2016-06-14 Troikaa Pharmaceuticals Limited Pharmaceutical compositions comprising paracetamol and process for preparing the same

Also Published As

Publication number Publication date
MA37811A1 (fr) 2016-10-31
KR102118227B1 (ko) 2020-06-03
ECSP15000500A (es) 2015-11-30
MX2014015402A (es) 2015-06-17
EA028909B1 (ru) 2018-01-31
CR20150036A (es) 2015-03-13
CN104487051B (zh) 2017-12-12
MA37811B1 (fr) 2017-07-31
MD4537C1 (ru) 2018-07-31
IL236423A (en) 2017-07-31
PE20150331A1 (es) 2015-03-07
PT2874602T (pt) 2016-07-13
CA2876801C (en) 2020-11-03
CU20140150A7 (es) 2015-10-27
US20150148379A1 (en) 2015-05-28
RS54844B1 (sr) 2016-10-31
BR112014032818A2 (pt) 2017-06-27
JP2015522004A (ja) 2015-08-03
PH12015500178B1 (en) 2015-04-06
MD4537B1 (ru) 2017-12-31
GEP201706689B (en) 2017-06-26
UA117101C2 (uk) 2018-06-25
BR112014032818B1 (pt) 2022-06-14
AU2013282753B2 (en) 2017-03-02
ME02431B (me) 2016-09-20
ES2578012T3 (es) 2016-07-20
JP5876620B2 (ja) 2016-03-02
EP2874602B1 (en) 2016-03-30
AR091633A1 (es) 2015-02-18
HRP20160706T1 (hr) 2016-08-12
PL2874602T3 (pl) 2016-10-31
US20160128955A1 (en) 2016-05-12
MY169251A (en) 2019-03-19
DOP2014000302A (es) 2015-03-15
ZA201409478B (en) 2016-01-27
CA2876801A1 (en) 2014-01-03
CL2014003536A1 (es) 2015-05-08
ITMI20121154A1 (it) 2013-12-30
SMT201600248B (it) 2016-08-31
EP2874602A1 (en) 2015-05-27
DK2874602T3 (en) 2016-07-04
NI201400147A (es) 2015-04-13
CY1117691T1 (el) 2017-05-17
CN104487051A (zh) 2015-04-01
US11344517B2 (en) 2022-05-31
IL236423A0 (en) 2015-02-26
PH12015500178A1 (en) 2015-04-06
HUE029431T2 (en) 2017-03-28
MD20140138A2 (ru) 2015-06-30
TN2014000526A1 (en) 2016-03-30
AU2013282753A1 (en) 2015-02-05
KR20150027160A (ko) 2015-03-11
SG11201408479WA (en) 2015-01-29
NZ703829A (en) 2016-06-24
SI2874602T1 (sl) 2016-09-30
AP2014008152A0 (en) 2014-12-31
WO2014002042A1 (en) 2014-01-03
CO7240357A2 (es) 2015-04-17
SG10201704482YA (en) 2017-07-28
MX369264B (es) 2019-11-04

Similar Documents

Publication Publication Date Title
EA201690044A1 (ru) Модуляторы ядерного транспорта и их применение
EA201590058A1 (ru) Аналоги глюкагона
BR112015026325A2 (pt) dosagem oral de compostos glp-1
EA201492050A1 (ru) Модуляторы ядерного транспорта и их применение
MX2013004406A (es) Tratamiento de diabetes mellitus usando inyecciones de insulina administradas con intervalos variables de inyeccion.
BR112015025354A2 (pt) compostos di-hidropirido-pirimidínicos como inibidores de autotaxina
MX2015002669A (es) Metodos de administracion de tratamiento con pirfenidona.
EA201491702A1 (ru) Оптимизированные терапевтические агенты для подкожного введения
EA201591618A1 (ru) Замещенные имидазопиридазины
EA201590697A1 (ru) Производные кетамина
EA201591698A1 (ru) Макроциклические ингибиторы киназы lrrk2
CO7101244A2 (es) Fenilimidazopirazoles sustituidos y su uso
CR20150324A (es) Polipéptidos estabilizados del factor de crecimiento tipo insulina
MX2015013091A (es) Metodos mejorados de uso para secretoglobinas humanas recombinantes.
EA201790973A1 (ru) A-антагонист в низкой дозировке для лечения adhd и болезни паркинсона
BR112017002449A2 (pt) tratamento de sintomas associados com terapia de privação androgênica
EA201500065A1 (ru) Инъецируемый супернасыщенный раствор ацетаминофена для спинального введения
UA111785C2 (uk) Композиція для лікування бородавок та спосіб лікування бородавок
UA95104U (uk) Спосіб терапії хворих на негоспітальну пневмонію з супутньою хсн
UA108267C2 (xx) Розчин моксифлоксацину для ін'єкцій
UA27471S (uk) Інсуліновий ін'єктор медичний
RU2012110137A (ru) Способ лечения инсулинорезистентности
RU2010124455A (ru) Способ лечения пострадавших с сочетанной черепно-мозговой травмой